96
Participants
Start Date
October 31, 2004
Primary Completion Date
September 30, 2009
Study Completion Date
September 30, 2009
AVX101
Alphavirus replicon particle vaccine expressing HIV Gag antigen
placebo
phosphate buffered saline, pH 7.2, HSA, sodium gluconate, and sucrose
Perinatal HIV Research Unit, Chris Hani Baragwanat, Bertsham
New York Blood Center - Union Square, New York
Columbia University, New York
New York Blood Center - Bronx, The Bronx
Vanderbilt University, Nashville
Johns Hopkins University, Baltimore
University of Rochester, Rochester
Botswana HIV Vaccine Clinical Eval. Ctr, Princess, Gaborone
Lead Sponsor
HIV Vaccine Trials Network
NETWORK
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
AlphaVax, Inc.
INDUSTRY